Inhibition of invasive properties of murine melanoma by bovine pancreatic DNase I in vitro and in vivo
Author:
Publisher
Pleiades Publishing Ltd
Subject
Structural Biology,Biophysics
Link
http://link.springer.com/content/pdf/10.1134/S0026893317040021.pdf
Reference54 articles.
1. Bhattarai D., Singh S., Jang Y., Hyeon Han S., Lee K., Choi Y. 2016. An insight into drug repositioning for the development of novel anti-cancer drugs. Curr. Top. Med. Chem. 16, 2156–2168.
2. Shimizu S. 2015. Development of anti-cancer drugs mediated by apoptosis and autophagy. Nihon Rinsho. 73, 1302–1307.
3. Hanusova V., Skalova L., Kralova V., Matouskova P. 2015. Potential anti-cancer drugs commonly used for other indications. Curr. Cancer Drug Targets. 15, 35–52.
4. Munoz M., Covenas R., Esteban F., Redondo M. 2015. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs. J. Biosci. 40, 441–463.
5. Harisa G.I., Alanazi F.K. 2014. Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs. Saudi Pharm. J. 22, 504–515.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nuclease-like metalloscissors: Biomimetic candidates for cancer and bacterial and viral infections therapy;Coordination Chemistry Reviews;2022-05
2. Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies;Frontiers in Oncology;2022-04-27
3. Human Recombinant DNase I (Pulmozyme®) Inhibits Lung Metastases in Murine Metastatic B16 Melanoma Model That Correlates with Restoration of the DNase Activity and the Decrease SINE/LINE and c-Myc Fragments in Blood Cell-Free DNA;International Journal of Molecular Sciences;2021-11-08
4. Cloning and characterization of a novel DNase gene from Trichogramma pretiosum;Protein Expression and Purification;2021-09
5. Targeting Circulating SINEs and LINEs with DNase I Provides Metastases Inhibition in Experimental Tumor Models;Molecular Therapy - Nucleic Acids;2020-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3